4 completed, 1 not yet recruiting, 1 terminated, 1 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Not yet recruiting 1, Terminated 1, Unknown 1 |
Follow Mycophenolate: new trials by email Literature Review of Mycophenolate trials Research Report on Mycophenolate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Utilization of a Microdevice for Psoriasis and Atopic Dermatitis In situ cutaneous microdevice, Triamcinolone, 5-Fluorouracil - Psoriasis, Atopic Dermatitis | Phase 4 | Not yet recruiting | University of California, San Francisco | 10 | 2026-08-01 | 2026-06-03 |
| Comparison between2 Drugs in Lupus Nephritis cyclo phosphamide, mycophenolate - Lupus Nephritis | Phase 4 | Completed | Al-Azhar University | 40 | 2021-04-05 | 2022-06-21 |
| Immune Monitoring to Facilitate Belatacept Monotherapy Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression | Phase 4 | Completed | Massachusetts General Hospital | 17 | 2020-02-11 | 2023-12-04 |
| Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients Reduced immunosuppression, Tacrolimus, mycophenolate - Immunosuppression After Renal Transplantation | Phase 4 | Unknown | Klemens Budde | 400 | 2017-12-01 | 2017-08-09 |
| Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients Belatacept, Tacrolimus, Mycophenolate - Implant or Graft; Rejection | Phase 4 | Completed | Columbia University | 57 | 2014-06-01 | 2021-02-10 |
| Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients sirolimus, tacrolimus, mycophenolate - Disorder Related to Renal Transplantation, Cytomegalovirus Infections | Phase 4 | Completed | Associação Médico Espírita de Botucatu | 48 | 2014-01-01 | 2016-02-17 |
| Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol Sirolimus, Azathioprine, Mycophenolate - Skin Cancer | Phase 4 | Terminated | Charite University, Berlin, Germany | 44 | 2007-01-01 | 2025-03-14 |
Cytomegalovirus Infections (1) · Delayed Graft Function (1) · Dermatitis, Atopic (1) · Lupus Nephritis (1) · Psoriasis (1) · Rejection, Psychology (1) · Skin Neoplasms (1)
Al-Azhar University (1) · Associação Médico Espírita de Botucatu (1) · Charite University, Berlin, Germany (1) · Columbia University (1) · Klemens Budde (1) · Massachusetts General Hospital (1) · University of California, San Francisco (1)
United States (3) · Egypt (1) · Germany (1)
Hannah Gilligan, MD (1) · Klemens Budde, MD (1) · Mark A. Hardy, MD (1) · Petra Reinke, Prof. Dr. (1) · Raymond Cho, MD, PhD (1)
2014 (1)